Correction to: The Journal of Antibiotics (2010) 63, 279–283; doi:10.1038/ja.2010.29
The authors of the above article noted an error in publication of this paper (AOP and in this issue) in Figures 4 and 5, whereby the wrong symbol was used to denote the absence of drug concentrations. The corrected figures and captions are shown below.
Effect of pargamicin A (a, b), melittin (c), vancomycin (d), arbekacin (e) and daptomycin (f) on membrane potential. Each point is the mean±s.d. of four estimates. Membrane potential assays were evaluated in the absence (open squares) or presence of the following concentrations of drugs: 1 × MIC (open circles), 2 × MIC (solid triangles), 4 × MIC (solid circles) and 8 × MIC (solid diamonds).
Loss of membrane function by pargamicin A (a, b), melittin (c), vancomycin (d), arbekacin (e) and daptomycin (f). Each point is the mean±s.d. of four estimates. Membrane function assays were evaluated in the absence (open squares) or presence of the following concentrations of drugs: 1 × MIC (open circles), 2 × MIC (solid triangles), 4 × MIC (solid circles) and 8 × MIC (solid diamonds).
Additional information
The online version of the original article can be found at 10.1038/ja.2010.29
Rights and permissions
About this article
Cite this article
Hashizume, H., Adachi, H., Igarashi, M. et al. Erratum: Biological activities of pargamicin A, a novel cyclic peptide antibiotic from Amycolatopsis sp.. J Antibiot 63, 339–340 (2010). https://doi.org/10.1038/ja.2010.37
Published:
Issue date:
DOI: https://doi.org/10.1038/ja.2010.37
